Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Ready Capital to Present at Nareit’s REITweek 2024
-
MIT Sloan Management Review Research Examines Circular Business Models' Benefit to Bottom Line and Increased Sustainability Measures
-
PureCycle Provides Update on Ironton Purification Facility
-
Modular Medical Announces Addition to the Russell Microcap(R) Index
-
Gryphon Digital Mining set to join Russell Microcap(R) Index
-
Element 29 Announces New Board Nominees
-
Ensysce Biosciences to Participate in the EPHMRA 2024 Annual Meeting
-
Early Warning Report Issued Pursuant to National Instrument 62-103 - Acquisition of Securities of Spanish Mountain Gold Ltd.
-
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
-
Aldo Mazzaferro Joins Headwall Partners
-
Millennial Potash Announces Private Placement For Proceeds Of Up To $2,000,000
-
Atlas Lithium to Co-host the Inaugural Brazil Lithium Summit
-
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survi
-
Gear Energy Ltd. Confirms Monthly Dividend for June of $0.005 per Share
-
Neurocrine Biosciences Presented CAHtalyst™ Phase 3 Pediatric and Adult Studies, CAHtalog™ Registry and Disease- and Glucocorticoid-Related Comorbidities Data in CAH at ENDO 2024
-
AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
-
Texas Must Close Primary Elections
-
Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies
-
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual Meeti
-
Promising Phase 2 Results For Biodexa's eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have a 100% Lifetime Risk of Colorectal Cancer
-
GOAI and Domain Development Corp Announce Strategic Partnership to Drive Revenue Growth
-
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
-
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
-
Genesis Offers New Tools and Incentives to Financial Industry Software Developers
-
CHATHAM ASSET MANAGEMENT SENDS LETTER TO SINCLAIR REGARDING REFINANCING EFFORTS
-
New $20 Million Research Funding Program Aims to 'Accelerate a Cure' for Follicular Lymphoma
-
Multichannel Contact Center, Incept, Empowers Frontline Workers With a New Ownership Asset Through Salt Labs
-
FIT KING Announces the Launch of the Recovery Pro Full Leg Compression Massage Boots for Sports Enthusiasts
-
NBA STAR CHRIS PAUL ANNOUNCED AS GREEN SPORTS ALLIANCE GUEST SPEAKER, NEWEST BOARD MEMBER
-
AU10TIX Q1 2024 Global Identity Fraud Report Identifies Online Gaming Industry as New ID Fraud Hotspot
-
LL Flooring Mails Letter to Shareholders Highlighting Board’s Highly Qualified and Engaged Directors
-
Neptune Flood Secures Over $300 Million of Premium Capacity for 2024 Hurricane Season
-
Industry Veteran Kevin Ziemba Joins JDC Group as VP of Delivery
-
Intended Purchases of Ordinary Shares to Satisfy Non-Employee Directors' Awards
-
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies
-
US Signal to Acquire OneNeck, Expanding Nationwide Data Center Footprint, IT Infrastructure Network
-
Obsidian Therapeutics Announces Additional OBX-115 Safety and Efficacy Data in Oral Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Mercantile Bank Corporation Implements Management Succession Plan
-
Sionna Therapeutics Announces Appointment of Jennifer Fitzpatrick as General Counsel
-
Frontier Announces Fiber Securitization Offering
-
BriaCell Presents Clinical Efficacy Data at ASCO 2024
-
Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting
-
7shifts Releases Annual Report 'What Restaurant Employees Want' to Assist Restaurant Operators With Their Biggest Challenges
-
Colombia's Keralty and UAE's Burjeel Holdings Announce Landmark Joint Venture for Cost-Efficient Healthcare Solutions in MENA
-
UroGen Pharma Appoints David Lin as New Chief Commercial Officer
-
REI Co-op to Opt Outside year-round: Co-op kicks off the summer with 300+ free classes and events across the country
-
Margaritaville at Sea Islander Launches with Power Knot Food Waste Biodigesters
-
Innovative Eyewear, Inc. to Participate in "Charting the Course: Navigating the Intersection of TMT and Business in the AI Era" Conference, June 4 - 5, 2024
-
Kyle Victor Joins Crest Hill Advisors as a Partner
-
Scale Computing Welcomes VMware Users With a Full System Exchange Trade-Up Offer
